Real-world survival differences in advanced biliary tract cancer patients with ctDNA detected IDH1 mutations and FGFR2 fusions receiving first-line gemcitabine-cisplatin with and without immunotherapy ...
Large language models (LLM) can generate treatment recommendations for straightforward cases of hepatocellular carcinoma (HCC ...
Large language models (LLM) can generate treatment recommendations for straightforward cases of hepatocellular carcinoma (HCC ...
The FDA issued a second CRL for rivoceranib and camrelizumab, with undisclosed reasons for non-approval. The combination therapy showed improved overall survival and progression-free survival compared ...
Liver cancer often develops in individuals with chronic liver disease, with hepatocellular carcinoma (HCC) and cholangiocarcinoma as the main types. HCC is commonly associated with hepatitis B or C, ...
Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...
The global incidence of liver cancer is projected to double by 2050. Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, and ...
MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback